Congressional Deal Targets Many Hemp THC Products but Skips VA Medical Cannabis Recommendation Authority

A major new federal spending deal is threatening to pull the rug out from under the hemp community. Congressional leaders have negotiated a bill that would essentially recriminalize many popular hemp-derived products, including Delta-8, by shifting the legal focus to total THC content. If passed, products would be capped at a tiny 0.4 milligrams of total THC, a move industry insiders warn could dismantle the $30 billion hemp market and eliminate thousands of jobs. To make matters worse, the deal completely ignores previously supported provisions that would have finally allowed VA doctors to recommend medical cannabis to veterans in legal states.

For everyday tokers, this is a massive red flag. Banning these products doesn't just limit your options at the local shop; it signals a coordinated push to stifle the broader cannabis movement, potentially fueled by competition from the alcohol industry. Losing access to hemp-derived cannabinoids and seeing our veterans denied medical guidance shows that despite state-level progress, the federal fight for fair access is hitting some serious turbulence. Keeping these alternative options legal is vital for maintaining a diverse and accessible market for everyone.